Masaki Kawabata

Chuo, 5418567, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction: Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: A Single-Center Retrospective Study.

Correction: Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: A Single-Center Retrospective Study.

Journal: Journal of gastrointestinal cancer

Published: August 15, 2026

Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: a Single-Center Retrospective Study.

Treatment Outcomes and Prognostic Factors in Patients With Pancreatic Adenosquamous Carcinoma: a Single-Center Retrospective Study.

Journal: Journal of gastrointestinal cancer

Published: December 31, 2025

Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma.

Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma.

Journal: International journal of clinical oncology

Published: December 29, 2025

Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer.

Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer.

Journal: Journal of gastrointestinal cancer

Published: August 27, 2025

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment.

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment.

Journal: Cancer reports (Hoboken, N.J.)

Published: May 18, 2025

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Journal: Cancer medicine

Published: April 23, 2025

Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Study.

Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 11, 2025

Hepatic reactive lymphoid hyperplasia diagnosed through post-ablation liver tumor biopsy.

Hepatic reactive lymphoid hyperplasia diagnosed through post-ablation liver tumor biopsy.

Journal: Clinical journal of gastroenterology

Published: March 10, 2025

Impact of zinc deficiency on the prognosis of unresectable pancreatic cancer.

Impact of zinc deficiency on the prognosis of unresectable pancreatic cancer.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: March 04, 2025

Efficacy of Locoregional Treatment for Oligo-Drug-Resistant Lesions during First-Line Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma: A Single-Center Retrospective Study.

Efficacy of Locoregional Treatment for Oligo-Drug-Resistant Lesions during First-Line Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma: A Single-Center Retrospective Study.

Journal: Oncology

Published: November 17, 2024

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants.

Journal: Cancer medicine

Published: February 11, 2024

Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.

Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.

Journal: Cancer gene therapy

Published: November 15, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026